Scott W. Lee

3.0k total citations · 2 hit papers
31 papers, 1.8k citations indexed

About

Scott W. Lee is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Scott W. Lee has authored 31 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Endocrinology, Diabetes and Metabolism, 17 papers in Surgery and 16 papers in Genetics. Recurrent topics in Scott W. Lee's work include Diabetes Management and Research (30 papers), Pancreatic function and diabetes (17 papers) and Diabetes and associated disorders (16 papers). Scott W. Lee is often cited by papers focused on Diabetes Management and Research (30 papers), Pancreatic function and diabetes (17 papers) and Diabetes and associated disorders (16 papers). Scott W. Lee collaborates with scholars based in United States, Ireland and Israel. Scott W. Lee's co-authors include Francine Kaufman, Bruce W. Bode, Satish K. Garg, Robert H. Slover, Richard M. Bergenstal, Timothy S. Bailey, John Shin, Ronald Brazg, John Welsh and Andrew Ahmann and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Diabetes.

In The Last Decade

Scott W. Lee

31 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia

2013 428 citations Richard M. Bergenstal, David C. Klonoff et al. New England Journal of Medicine profile →
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes

2017 415 citations Satish K. Garg, Bruce A. Buckingham et al. Diabetes Technology & Therapeutics profile →

Peers

Countries citing papers authored by Scott W. Lee

Since Specialization

Citations

This map shows the geographic impact of Scott W. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott W. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott W. Lee more than expected).

Fields of papers citing papers by Scott W. Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott W. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott W. Lee. The network helps show where Scott W. Lee may publish in the future.

Co-authorship network of co-authors of Scott W. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Scott W. Lee. A scholar is included among the top collaborators of Scott W. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott W. Lee. Scott W. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety Event Outcomes and Glycemic Control with a Hybrid Closed-Loop System Used by Chinese Adolescents and Adults with Type 1 Diabetes Mellitus 2023 ·Diabetes Technology & Therapeutics ·Pei Yu, Weijian Ke, Jing Lü, (unknown), Zhijian Zhang, Yongde Peng, Yan Bi, Yanbing Li, (unknown), Xiaolu Zhang, Xiaoxiao Chen, (unknown), Scott W. Lee, John Shin, Andrew S. Rhinehart, Robert A. Vigersky, Yiming Mu	3
2	Glycemic outcomes of children 2–6 years of age with type 1 diabetes during the pediatric MiniMed ™ 670G system trial 2022 ·Pediatric Diabetes ·Gregory P. Forlenza, Laya Ekhlaspour, Linda A. DiMeglio, Larry A. Fox, Henry Rodriguez, Dorothy I. Shulman, Kevin B. Kaiserman, David R. Liljenquist, John Shin, Scott W. Lee, Bruce A. Buckingham	41
3	Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 Diabetes 2018 ·Diabetes Technology & Therapeutics ·Gregory P. Forlenza, Orit Pinhas‐Hamiel, David R. Liljenquist, Dorothy I. Shulman, Timothy S. Bailey, Bruce W. Bode, Michael A. Wood, Bruce A. Buckingham, Kevin B. Kaiserman, John Shin, Suiying Huang, Scott W. Lee, Francine Kaufman	138
4	In-Clinic Evaluation of the MiniMed 670G System “Suspend Before Low” Feature in Children with Type 1 Diabetes 2018 ·Diabetes Technology & Therapeutics ·Michael A. Wood, Dorothy I. Shulman, Gregory P. Forlenza, Bruce W. Bode, Orit Pinhas‐Hamiel, Bruce A. Buckingham, Kevin B. Kaiserman, David R. Liljenquist, Timothy S. Bailey, John Shin, Suiying Huang, Xiaoxiao Chen, Toni L. Cordero, Scott W. Lee, Francine Kaufman	18
5	IMPROVED HBA1C, TOTAL DAILY INSULIN DOSE, AND TREATMENT SATISFACTION WITH INSULIN PUMP THERAPY COMPARED TO MULTIPLE DAILY INSULIN INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES IRRESPECTIVE OF BASELINE C-PEPTIDE LEVELS 2018 ·Endocrine Practice ·Robert A. Vigersky, Suiying Huang, Toni L. Cordero, John Shin, Scott W. Lee, (unknown), Francine Kaufman, Ohad Cohen	27
6	Accuracy of a Fourth-Generation Continuous Glucose Monitoring System in Children and Adolescents with Type 1 Diabetes 2018 ·Diabetes Technology & Therapeutics ·Robert H. Slover, Jeanie B. Tryggestad, Linda A. DiMeglio, Larry A. Fox, Bruce W. Bode, Timothy S. Bailey, Ronald Brazg, Mark P. Christiansen, Jennifer L. Sherr, Eva Tsalikian, Kevin B. Kaiserman, Ashley F. Sullivan, Suiying Huang, John Shin, Scott W. Lee, Francine Kaufman	24
7	Complex Assessment of Metabolic Effectiveness of Insulin Pump Therapy in Patients with Type 2 Diabetes Beyond HbA1c Reduction 2017 ·Diabetes Technology & Therapeutics ·Rudolf Chlup, (unknown), Javier Castañeda, Scott W. Lee, Xuan Linh Nguyen, Ohad Cohen	17
8	The Effect of Prior Continuous Glucose Monitoring Use on Glycemic Outcomes in the Pivotal Trial of the MiniMed ^™ 670G Hybrid Closed-Loop System 2017 ·Diabetes Technology & Therapeutics ·Toni L. Cordero, Satish K. Garg, Ronald Brazg, Timothy S. Bailey, John Shin, Scott W. Lee, Francine Kaufman	15
9	Accuracy and Acceptability of the 6-Day Enlite Continuous Subcutaneous Glucose Sensor 2014 ·Diabetes Technology & Therapeutics ·Timothy S. Bailey, Andrew Ahmann, Ronald Brazg, Mark P. Christiansen, Satish K. Garg, (unknown), John Welsh, Scott W. Lee	71
10	Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial 2014 ·The Lancet ·Yves Reznik, Ohad Cohen, Ronnie Aronson, Ignacio Conget, (unknown), Javier Castañeda, Scott W. Lee	148
11	The PILGRIM Study: In Silico Modeling of a Predictive Low Glucose Management System and Feasibility in Youth with Type 1 Diabetes During Exercise 2014 ·Diabetes Technology & Therapeutics ·Thomas Danne, (unknown), Olga Kordonouri, (unknown), K Remus, Anirban Roy, (unknown), Scott W. Lee, Francine Kaufman	60
12	Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia breakdown → 2013 ·New England Journal of Medicine ·Richard M. Bergenstal, David C. Klonoff, Satish K. Garg, Bruce W. Bode, Melissa Meredith, Robert H. Slover, Andrew Ahmann, John Welsh, Scott W. Lee, Francine Kaufman	428
13	ASPIRE in-Home: Rationale, Design, and Methods of a Study to Evaluate the Safety and Efficacy of Automatic Insulin Suspension for Nocturnal Hypoglycemia 2013 ·Journal of Diabetes Science and Technology ·David C. Klonoff, Richard M. Bergenstal, Satish K. Garg, Bruce W. Bode, Melissa Meredith, Robert H. Slover, Andrew Ahmann, John Welsh, Scott W. Lee	7
14	Accuracy of the Enlite 6-Day Glucose Sensor with Guardian and Veo Calibration Algorithms 2011 ·Diabetes Technology & Therapeutics ·D. Barry Keenan, John J. Mastrototaro, Howard Zisser, (unknown), (unknown), Scott W. Lee, (unknown), Timothy S. Bailey, Ronald Brazg, (unknown)	77
15	The ASPIRE Study: Design and Methods of an In-Clinic Crossover Trial on the Efficacy of Automatic Insulin Pump Suspension in Exercise-Induced Hypoglycemia 2011 ·Journal of Diabetes Science and Technology ·Ronald Brazg, Timothy S. Bailey, Satish K. Garg, Bruce A. Buckingham, Robert H. Slover, David C. Klonoff, Xuan Linh Nguyen, John Shin, John Welsh, Scott W. Lee	18
16	Resource utilization with insulin pump therapy for type 2 diabetes mellitus. 2010 ·PubMed ·Peter Lynch, Aylin Riedel, (unknown), Ying Fan, Tim Peoples, (unknown), Scott W. Lee	17
17	Improved A1C by switching to continuous subcutaneous insulin infusion from injection insulin therapy in type 2 diabetes: A retrospective claims analysis 2010 ·Primary care diabetes ·Peter Lynch, Aylin Riedel, (unknown), Ying Fan, Tim Peoples, (unknown), Scott W. Lee	10
18	Retrospective Analysis of Diabetes Care in California Medicaid Patients with Mental Illness 2009 ·Journal of General Internal Medicine ·Jim E. Banta, Elaine H. Morrato, Scott W. Lee, Mark G. Haviland	19
19	Combined Insulin Pump Therapy with Real-Time Continuous Glucose Monitoring Significantly Improves Glycemic Control Compared to Multiple Daily Injection Therapy in Pump Naïve Patients with Type 1 Diabetes; Single Center Pilot Study Experience 2007 ·Journal of Diabetes Science and Technology ·Scott W. Lee, (unknown), (unknown), (unknown), (unknown), Anthony Firek, (unknown), Jerrold S. Petrofsky	18
20	Current Perspectives on the Use of Continuous Subcutaneous Insulin Infusion in the Acute Care Setting and Overview of Therapy 2004 ·Critical Care Nursing Quarterly ·Scott W. Lee, (unknown), (unknown)	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact